New York, NY -- (ReleaseWire) -- 11/08/2012 --TagLikeMe Corp. (PINK:TAGG) traded in the range of $0.08 and $0.12 during its latest trading session. The stock had opened at $0.12 and closed at $0.09, down 31.55 percent from its previous close of $0.12. TagLikeMe has its first support level at $0.06 while it faces the resistance at $0.11. If the stock breaches $0.11, it may go as high as $0.15. TagLikeMe recorded the volume of 73.296 million shares, which is significantly higher than its average daily trading volume of 22.426 shares. The stock has sunk at high volume showing bearish trend in the short term and medium time period.
Get all the necessary info on whether or not trade TAGG by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=TAGG
Medical Marijuana Inc. (PINK:MJNA) stock closed its latest trading session at $0.14, up 22.04 percent from its previous close of $0.11. However, its today’s volume of 30.392 million shares was higher than its usual trading volume of 5.817 million shares. The stock opened the session at $0.14 and touched its highest price point at $0.16. Medical Marijuana stock’s lowest price point for the session stood at $0.13. The stock’s MACD chart shows bullish trend in the short term. Its first resistance level is at $0.15. Upon breaching its first support level of $0.12 the stock may fall to $0.11 level.
Find out if MJNA can maintain the momentum by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=MJNA
Cannabis Science Inc. (PINK:CBIS) traded in the range of $0.05 and $0.06 during its latest trading session. The stock had opened at $0.05 and closed 14.68 percent up from its previous close. Cannabis Science recorded the volume of 17.755 million shares. Its average daily trading volume stands at 4.97 million shares. Its MACD chart shows bullish trend and the stock may go as high as $0.06 in the coming sessions. Its first support level stands at $0.04, breaching this level, the stock may tumble to $0.03. Cannabis Science stock is trading in line with its very short term EMA price of $0.05.
Find out more about CBIS by reading the full trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=CBIS
PacWest Equities Inc. (PINK:PWEID) stock closed its latest trading session at $0.73, up 19.64 percent from its previous close of $0.61. The stock opened the session at $0.62 and touched its highest price point at $0.75. PacWest Equities stock’s lowest price point for the session stood at $0.60. The stock is likely to maintain its bearish trend in the near term and medium term as shown by its MACD chart. PacWest Equities stock may touch $0.35 level in the coming trading sessions. It is also trading below its short term and medium term EMA price of $0.18 and $2.88 respectively, confirming bearish trend.
Read the free trend analysis report to help on all decisions regarding PWEID: http://www.wallstreetreport.net/market-scan/?symbol=PWEID
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors you to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetReport.net
Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.
Alexander K. Neumann
WALL STREET REPORT